Analys

Navigo (Q3 review): Nascent recovery - Redeye

Navigo (Q3 review): Nascent recovery - Redeye

Redeye updates its estimates and valuation following Navigo releasing its Q3 2025 report. Adjusted EBIT beat our projection, and cyclical subsidiaries seem to face a nascent market recovery. Nordisk Bergteknik’s share price has continued to rise since the end of Q3, boding well for NAV growth.

Länk till analysen i sin helhet: https://www.redeye.se/research/1139234/navigo-q3-review-nascent-recovery?utm_source=finwire&utm_medium=RSS